ALDOC
Fructose-bisphosphate aldolase C
Also known as: ALDOC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09972
- Gene
- ALDOC
- Ensembl
- ENSG00000109107
- Chromosome
- 17
- Canonical length
- 364 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the class I fructose-biphosphate aldolase gene family. Expressed specifically in the hippocampus and Purkinje cells of the brain, the encoded protein is a glycolytic enzyme that catalyzes the reversible aldol cleavage of fructose-1,6-biphosphate and fructose 1-phosphate to dihydroxyacetone phosphate and either glyceraldehyde-3-phosphate or glyceraldehyde, respectively. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>P09972|ALDOC
1 MPHSYPALSA EQKKELSDIA LRIVAPGKGI LAADESVGSM AKRLSQIGVE NTEENRRLYR
61 QVLFSADDRV KKCIGGVIFF HETLYQKDDN GVPFVRTIQD KGIVVGIKVD KGVVPLAGTD
121 GETTTQGLDG LSERCAQYKK DGADFAKWRC VLKISERTPS ALAILENANV LARYASICQQ
181 NGIVPIVEPE ILPDGDHDLK RCQYVTEKVL AAVYKALSDH HVYLEGTLLK PNMVTPGHAC
241 PIKYTPEEIA MATVTALRRT VPPAVPGVTF LSGGQSEEEA SFNLNAINRC PLPRPWALTF
301 SYGRALQASA LNAWRGQRDN AGAATEEFIK RAEVNGLAAQ GKYEGSGEDG GAAAQSLYIA
361 NHAYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALDOC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 1,156 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 1,156 nTPM
- retina: 1,098 nTPM
- amygdala: 1,056 nTPM
- cerebellum: 1,048 nTPM
- basal ganglia: 987 nTPM
- midbrain: 806 nTPM
Single-cell type
- astrocytes: 106 nCPM
- bergmann glia: 88 nCPM
- oligodendrocyte progenitor cells: 46 nCPM
- other brain neurons: 45 nCPM
- brain inhibitory neurons: 39 nCPM
- brain excitatory neurons: 34 nCPM
Immune cell
- T-reg: 41 nTPM
- naive CD4 T-cell: 38 nTPM
- MAIT T-cell: 31 nTPM
- memory CD4 T-cell: 30 nTPM
- NK-cell: 30 nTPM
- naive CD8 T-cell: 29 nTPM
Brain region
- pons: 1,735 nTPM
- cerebellum: 1,428 nTPM
- medulla oblongata: 1,347 nTPM
- cerebral cortex: 1,250 nTPM
- thalamus: 1,159 nTPM
- midbrain: 860 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALDOC.
Disease | ImmuneIEDB
Conditions an epitope on ALDOC was assayed in.
- multiple sclerosis B cell
- onchocerciasis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- -0.33
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- epithelial cell differentiation
- fructose 1,6-bisphosphate metabolic process
- fructose metabolic process
- gluconeogenesis
- glycolytic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ALDOC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALDOC as an antibody target. Whether an autoantibody or antibody against ALDOC could matter depends on whether native ALDOC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALDOC is annotated as secreted, so native ALDOC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ALDOC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...